Project description:Pancreatic adenosquamous carcinoma (PASC) is an aggressive cancer whose mutational origins are poorly understood. An early study reported high-frequency somatic mutations affecting UPF1, a core nonsense-mediated mRNA decay (NMD) factor, in PASC, but subsequent studies did not observe these lesions. The corresponding controversy about whether UPF1 mutations are important contributors to PASC has been exacerbated by a paucity of functional studies. Here, we modeled two UPF1 mutations to find no significant effects on pancreatic cancer growth, acquisition of adenosquamous features, UPF1 splicing, UPF1 protein levels, or NMD efficiency. We subsequently discovered that ~40% of UPF1 mutations reportedly present in PASCs are identical to standing genetic variants in the human population, suggesting that they may be non-pathogenic inherited variants rather than pathogenic mutations. Our data suggest that UPF1 is not a common functional driver of PASC and motivate further attempts to identify unique genetic features defining these malignancies.

2020-12-19 | GSE163517 | GEO

Chemotherapy is associated with improved survival in a national cohort of stage IV pancreatic adenosquamous carcinoma.

Project description: Not available

| S-EPMC9830350 | biostudies-literature

A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins.

Project description: Not available

| S-EPMC3612900 | biostudies-literature

Two rare cases of pancreatic adenosquamous carcinoma: A review of the literature with focus on radiologic findings.

Project description: Not available

| S-EPMC6554233 | biostudies-literature